These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 2856939

  • 1. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [Abstract] [Full Text] [Related]

  • 2. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB, Schmidt WK, Kuhar MJ.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [Abstract] [Full Text] [Related]

  • 3. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
    Clark JA, Liu L, Price M, Hersh B, Edelson M, Pasternak GW.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
    [Abstract] [Full Text] [Related]

  • 4. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL, Brown SR, Puttfarcken P, Cox BM.
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [Abstract] [Full Text] [Related]

  • 5. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J, Sánchez-Blázquez P, Lee NM.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [Abstract] [Full Text] [Related]

  • 6. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 7. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

  • 8. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL, Zarr GD, Brown SR, Cox BM.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [Abstract] [Full Text] [Related]

  • 9. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM.
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S, Bhargava HN.
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [Abstract] [Full Text] [Related]

  • 11. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA.
    Arzneimittelforschung; 1985 Aug; 35(1A):447-51. PubMed ID: 2985096
    [Abstract] [Full Text] [Related]

  • 12. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B, Gouardères C, Mazarguil H, Audigier Y, Cros J.
    Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
    [Abstract] [Full Text] [Related]

  • 13. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J, Benyhe S, Hepp J, Khan A, Borsodi A, Szücs M, Medzihradszky K, Wollemann M.
    Neuropeptides; 1987 Jul; 10(1):19-28. PubMed ID: 2890119
    [Abstract] [Full Text] [Related]

  • 14. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL.
    J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
    [Abstract] [Full Text] [Related]

  • 15. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
    Ishizuka Y, Oka T.
    Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
    [Abstract] [Full Text] [Related]

  • 16. Opioid ligand binding sites in the spinal cord of the guinea-pig.
    Zarr GD, Werling LL, Brown SR, Cox BM.
    Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
    [Abstract] [Full Text] [Related]

  • 17. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO, Lang MA, Cruciani RA, Russell JT, Gainer H, Rodbard D.
    NIDA Res Monogr; 1986 May; 75():77-80. PubMed ID: 2893283
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of 3H-tifluadom binding in guinea-pig brain membranes.
    Burkard WP, Müller PM, Flück N.
    J Recept Res; 1984 May; 4(1-6):165-73. PubMed ID: 6151988
    [Abstract] [Full Text] [Related]

  • 19. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [Abstract] [Full Text] [Related]

  • 20. Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.
    Pfeiffer A, Herz A.
    Mol Pharmacol; 1982 Mar; 21(2):266-71. PubMed ID: 6124875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.